奶昔直播官方版-奶昔直播直播视频在线观看免费版下载-奶昔直播安卓版本免费安装

課程報名咨詢電話:010-51268840 51268841
英語 | 小語種 | 考研 | 在職研 | 財會 | 公務(wù)員 | 人力資源 | 出國留學(xué) | 冬令營 | 企業(yè)管理 | 高校 | 高考 | 文體 | 0-18歲 | 網(wǎng)絡(luò)課堂
 外語招生網(wǎng)
 外語報名咨詢熱線:010-51294614、51299614 �。� 熱點:環(huán)球雅思部分課程9.5折特惠 限時搶報!
 雅思·IELTS新托�!OEFL四六級PETS商務(wù)英語職稱英語小語種翻譯少兒英語GREGMAT | 其他外語考試

Flu vaccine production in pipeline

作者:不詳   發(fā)布時間:2009-09-05 11:48:38  來源:網(wǎng)絡(luò)
  • 文章正文
  • 調(diào)查
  • 熱評
  • 論壇
  China is set to be the first country to mass-produce a vaccine against the A(H1N1) flu pandemic, which scientists warn might erupt this fall and winter.
  After passing a panel of experts certification organized by the State Food and Drug Administration (SFDA) Monday, the vaccine is expected to be approved by the government this week.
  The vaccine was developed by Beijing-based Sinovac.
  The A(H1N1) influenza vaccine would be appropriate for anyone aged 3 to 60, said vaccine expert Zhao Kai, who is with SFDA’s Drug Evaluation Center.
  Only one shot is needed for inoculation.
  "It’s up to the international standard for safety and immunogenicity factors," Zhao said Monday at the experts certification meeting.
  Vice-Health Minister Yin Li Monday emphasized the importance of vaccination.
  "Local health departments should organize vulnerable groups for inoculation when A(H1N1) flu vaccination regulations are issued," he said.
  An online survey by the news portal Sohu.com found that 68.4 percent of the 2,269 respondents said they wanted to be vaccinated.
  However, questions remain over such issues as when people will get the shot, how long the protection can last and what its price will be.
  The vaccine will go into the national strategic stockpile instead of the marketplace and the Ministry of Health will devise a national inoculation plan, said Yang Jinrui, with the ministry’s press office.
  "Safety is always the top priority, thus it cannot be compromised by urgency," said Liang Wannian, vice director of the ministry’s emergency office.
  Health authorities will closely watch its safety after large-scale inoculation. No major adverse reactions were detected in clinical trials, said Li Guoqing, who heads the SFDA’s Drug Evaluation Center.
  The government will be responsible for any serious side effects from the vaccine, he said.
  Vivian Tan, press officer with the World Health Organization Beijing office, said Monday that the office had no details on the Sinovac clinical trials or the government’s approval process, but gave recommendations on the immunization protocol.
  Suggested target groups are healthcare workers, who are more likely to be exposed to the virus, pregnant women, people aged above 6 months with chronic medical conditions such as respiratory and cardiovascular diseases, healthy adults aged 15-49 and children.
  "Each country should adapt rules based on their own situations," she added.
  Health Minister Chen Zhu said previously that China would prepare enough A(H1N1) vaccines for 5 percent of the population by year’s end.
  Keiji Fukuda, assistant director-general of the World Health Organization, said given the population size, vaccine manufacturers in China face a huge challenge in expanding the production capacity to meet potential needs.
  Xinhua reported on Wednesday that the Mexican government would buy 10 million doses of A(H1N1) flu vaccine from China, bringing its stockpile to 30 million doses, nearly 30 percent of its population.
  Yang, of the Ministry of Health, refused to confirm the Mexico deal, but he said there are countries wanting to buy the vaccine from China, and they had contacted the ministry.
  Nearly 75 percent of those polled in the Sohu.com survey said they opposed selling vaccine to other countries, saying it should first protect the Chinese.
  "If used in the right areas and for specific groups, the amount of vaccine would work well to block the virus spreading among the people," said Zeng Guang, a senior epidemiologist at the Chinese Centers for Disease Control and Prevention.
  The Ministry of Health Monday called on the public to fight against A(H1N1) flu as risks are rising amid recent cases of group infection.
以下網(wǎng)友留言只代表網(wǎng)友個人觀點,不代表本站觀點。 立即發(fā)表評論
提交評論后,請及時刷新頁面!               [回復(fù)本貼]    
用戶名: 密碼:
驗證碼: 匿名發(fā)表
外語招生最新熱貼:
【責(zé)任編輯:蘇婧  糾錯
【育路網(wǎng)版權(quán)與免責(zé)聲明】  
    ① 凡本網(wǎng)注明稿件來源為"原創(chuàng)"的所有文字、圖片和音視頻稿件,版權(quán)均屬本網(wǎng)所有。任何媒體、網(wǎng)站或個人轉(zhuǎn)載、鏈接、轉(zhuǎn)貼或以其他方式復(fù)制發(fā)表時必須注明"稿件來源:育路網(wǎng)",違者本網(wǎng)將依法追究責(zé)任;
    ② 本網(wǎng)部分稿件來源于網(wǎng)絡(luò),任何單位或個人認為育路網(wǎng)發(fā)布的內(nèi)容可能涉嫌侵犯其合法權(quán)益,應(yīng)該及時向育路網(wǎng)書面反饋,并提供身份證明、權(quán)屬證明及詳細侵權(quán)情況證明,育路網(wǎng)在收到上述法律文件后,將會盡快移除被控侵權(quán)內(nèi)容。
外語報名咨詢電話:010-51294614、51299614
外語課程分類
 
-- 大學(xué)英語---
專四專八英語四六級公共英語考研英語
-- 出國考試---
雅思托福GREGMAT
-- 職業(yè)英語---
BEC翻譯職稱英語金融英語托業(yè)
博思實用商務(wù)面試英語
-- 實用英語---
口語新概念外語沙龍口語夢工場口語
VIP翻譯
-- 小語種----
日語法語德語韓語俄語阿拉伯語
西班牙語意大利語其它語種
熱點專題·精品課程
 
外語課程搜索
課程關(guān)鍵詞:
開課時間:
價格范圍: 元 至
課程類別:
學(xué)員報名服務(wù)中心: 北京北三環(huán)西路32號恒潤中心1806(交通位置圖
咨詢電話:北京- 010-51268840/41 傳真:010-51418040 上海- 021-51567016/17
育路網(wǎng)-中國新銳教育社區(qū): 北京站 | 上海站 | 鄭州站| 天津站
本站法律顧問:邱清榮律師
北京育路互聯(lián)科技有限公司版權(quán)所有1999-2009 | 京ICP備05012189號